Related Experiment Videos
Role of platelet activation in dementia
F van Kooten1, G Ciabattoni, C Patrono
1Department of Neurology, University Hospital Rotterdam, The Netherlands. vankooten@neuro.fgg.eur.nl
Insights
Platelet activation is linked to stroke and dementia. More research is needed on how platelet activation affects dementia and if antiplatelet drugs like aspirin are effective and safe for cognitive health.
Area of Science:
- Cardiovascular Science
- Neurology
- Gerontology
Background:
- Platelets are crucial in atherosclerosis and stroke development.
- Stroke is a significant risk factor for dementia, affecting about 25% of stroke survivors.
- Platelet activation is implicated in both stroke and dementia.
Purpose of the Study:
- To review studies on platelet activation in stroke and dementia patients.
- To examine the impact of antiplatelet medications on cognitive function and dementia.
- To identify gaps in current research regarding platelet activation and dementia.
Main Methods:
- Literature review of studies on platelet activation in stroke.
- Literature review of studies on platelet activation in dementia.
- Review of research on antiplatelet drugs (aspirin, NSAIDs) and cognitive outcomes.
Main Results:
- Increased platelet activation is observed in patients with stroke and dementia.
- Limited studies suggest potential effects of antiplatelet agents on cognitive function.
- Mechanisms linking platelet activation to dementia remain unclear.
Conclusions:
- Further research is required to understand the mechanisms and factors influencing platelet activation in dementia.
- Randomized controlled trials are necessary to evaluate the efficacy and safety of antiplatelet interventions for dementia prevention or treatment.
Abstract:
Platelets play an important role in atherosclerosis, and increased platelet activation is associated with stroke. Stroke is an important risk factor for dementia, as approximately 25% of the patients are demented after stroke. In this review, we describe platelet activation studies in patients with stroke and with dementia. In addition, we review the few studies that have investigated the effect of antiplatelet medication such as aspirin and non-steroidal anti-inflammatory drugs on cognitive function and the occurrence of dementia. We conclude that further studies are needed to characterize the mechanisms and determinants of platelet activation in relation to the development of dementia. Furthermore, the efficacy and safety of antiplatelet intervention will have to be assessed in properly designed randomized trials.